The management of Leishmania donova ni (LD), responsible for fatal visceral leishmaniasis (VL), faces increasing challenges due to rising drug-unresponsiveness, leading to increasing treatment ...
Thermo Fisher returned to growth in 4Q 2024 with 6.6% projected EPS growth. Learn why TMO stock’s leadership position and ...
Image credit: Thermo Fisher Scientific Inc. Thermo Fisher Scientific plans to drive share gain, execute mergers and acquisitions (M&As), and benefit from a gap in the sterile fill-finish market due to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback